Not Yet RecruitingNot Applicable

Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab

United States30 participantsStarted 2026-03-01

Plain-language summary

The main goal of this study is to test a virtual reality (VR) program, Survivors' Virtual Reality Survivorship Experience (SurviVRSE), designed to help Breast Cancer survivors (n=30) learn about heart health. The aims are to test the usability, feasibility, and acceptability o the intervention. Additionally, follow-up assessments will examine changes in women's cancer therapy related cardiac dysfunction knowledge and heart healthy behaviors (e.g., physical activity).

Who can participate

Age range18 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * 18 years of age or older * Able to speak and read in English * Actively receiving Trastuzumab or an anthracycline-based treatment * Diagnosed with stages 0-III Breast Cancer Exclusion Criteria: \- History of prior Breast Cancer diagnosis (i.e., not their first breast cancer diagnosis)

What they're measuring

CTRCD Knowledge

Timeframe: Baseline, within 2 days post-Intervention, and 4 weeks post-intervention

Usability

Timeframe: Within 2 days post-Intervention

Acceptability

Timeframe: Within 2 days post-Intervention

User Satisfaction

Timeframe: Within 2 days post-Intervention

Trial details

NCT IDNCT07426913

SponsorVirginia Commonwealth University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06-30

Contact for this trial

Arnethea Sutton, Ph.D

8048277363 careslab@vcu.edu

View on ClinicalTrials.gov More Breast Cancer trials